KKR to Acquire Healthium from Apax Funds
06 5월 2024 - 3:01PM
Business Wire
KKR, a leading global investment firm, today announced the
signing of definitive agreements under which funds managed by KKR
will acquire Healthium Medtech Ltd. (“Healthium”), a leading Indian
medical devices company, from an affiliate of Funds advised by Apax
Partners LLP (“Apax”), a leading global private equity advisory
firm. The acquisition will be made by a special purpose vehicle
owned by KKR-managed funds which will acquire a controlling
interest in Healthium group, including Healthium.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240505117673/en/
Founded in India in 1992, Healthium is a medical devices company
that develops, manufactures and sells a broad range of surgical
products globally. Its comprehensive, high-quality portfolio caters
to a wide spectrum of surgeons’ needs, offering wound closure,
arthroscopy, and advanced wound closure products.
The Apax Funds acquired Healthium in 2018 and transformed the
company from a domestic suture player into a global medical devices
leader. With the support of the Apax Funds, the company bolstered
its management team to add deep industry experience with the
appointment of Anish Bafna as CEO and Vishal Maheshwari as CFO,
positioning Healthium for growth. Healthium strengthened its
existing portfolio of wound closure devices and consumables and
invested in new franchises such as arthroscopy and advanced wound
care through in-house R&D and M&A. During this period,
Healthium expanded its presence from 50 countries to more than 90
today.
Akshay Tanna, Partner and Head of India Private Equity at
KKR, said: “Under the leadership of Anish and his talented
management team, Healthium has established itself as a leading
homegrown producer of medical devices with a strong track record of
delivering quality products and a wide distribution network both in
India and globally. We look forward to leveraging our global
network and healthcare expertise to accelerate its growth in this
fast-growing sector and further scale its global business through
organic and inorganic growth strategies.”
Steven Dyson, Partner at Apax, commented: “Thanks to our
long experience partnering with medical devices companies, we saw
the opportunity to leverage Healthium’s strong existing portfolio
to create a global diversified MedTech platform. We are proud to
have supported Healthium on its growth journey to become the
leading medical technology player in India through investments in
innovation, manufacturing capacity, and portfolio expansion. We
would like to thank Anish, Vishal and the team, and wish them every
success for the future.”
Anish Bafna, Chief Executive Officer of Healthium, said:
“Over the last five years, with the support and partnership of
Apax, Healthium has tremendously accelerated its growth. Our
products are now used in one-in-five surgeries globally and we have
nearly doubled the markets we’re present in. On behalf of the whole
management team, I would like to thank the Apax team for their
expertise, hard work, and dedication. As we look to further
strengthen and expand our market position, we are delighted to
welcome an investor of KKR’s calibre, who brings deep global
healthcare expertise and knowledge of the Indian market. We look
forward to our next phase of growth with their support, being able
to leverage their global platform, as well as strong investment and
operational expertise.”
KKR makes its investment from its Asian Fund IV. Healthium marks
KKR’s latest investment in the healthcare sector in India and Asia
Pacific, which includes but is not limited to, JB, a leading
branded formulations pharmaceutical company in India; Max
Healthcare, one of India’s largest hospital networks; Gland Pharma,
a leading Indian pure-play generic injectable pharmaceutical
products company; PHC, a leading provider of medical equipment and
clinical healthcare IT systems in Japan; Bushu Pharma, a leading
pure-play contract development and manufacturing company in Japan;
and Metro Pacific Hospitals, the largest private hospital chain in
the Philippines.
The transaction is subject to receipt of certain regulatory
approvals and is expected to close in the third quarter of 2024.
Financial details were not disclosed.
Apax Partners and Healthium were advised by Jefferies LLC as
financial advisor and Kirkland & Ellis LLP as legal counsel.
KKR was advised by Moelis & Company as financial advisor and
Simpson Thacher & Bartlett and AZB & Partners as legal
counsel.
About Healthium
Healthium is a global medical devices company focused on
products used in surgical, post-surgical and chronic care. Fuelled
by its vision to provide “Access to precision medtech for every
patient, globally," it is present across 90 countries. 1 in 5
surgeries conducted globally uses a Healthium product.
www.healthiummedtech.com
About KKR
KKR is a leading global investment firm that offers alternative
asset management as well as capital markets and insurance
solutions. KKR aims to generate attractive investment returns by
following a patient and disciplined investment approach, employing
world-class people, and supporting growth in its portfolio
companies and communities. KKR sponsors investment funds that
invest in private equity, credit and real assets and has strategic
partners that manage hedge funds. KKR’s insurance subsidiaries
offer retirement, life and reinsurance products under the
management of Global Atlantic Financial Group. References to KKR’s
investments may include the activities of its sponsored funds and
insurance subsidiaries. For additional information about KKR &
Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com.
For additional information about Global Atlantic Financial Group,
please visit Global Atlantic Financial Group’s website at
www.globalatlantic.com.
About Apax
Apax Partners LLP (“Apax”) is a leading global private equity
advisory firm. For over 50 years, Apax has worked to inspire growth
and ideas that transform businesses. The firm has raised and
advised funds with aggregate commitments of more than $77 billion.
These funds provide long-term equity financing to build and
strengthen world-class companies. For further information, please
visit www.apax.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240505117673/en/
Media Inquiries For KKR Wei
Jun Ong +65 6922 5813 WeiJun.Ong@kkr.com
For Apax Kat Sallerfors +44 20 7872 6300
Katarina.sallerfors@apax.com
KKR (NYSE:KKR)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
KKR (NYSE:KKR)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024